Effects of bFGF on decrease of HG-induced accumulation of intracellular ROS levels. by Yuan Hu Xuan (632639)

Tempol and L-NAME help prevent the decrease in F_max. by Travis L. Dutka (321984)

Apicoplast inhibitors decrease global parasite prenylation in the second IDC after treatment. by Kit Kennedy (4915510)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)

Cell-penetrating 15mer peptides decrease the proliferation and viability of cancer cells. by Pavan Kumar Puvvula (10495853)

Thimerosal decreases the expression of survivin via the PI3K/Akt pathway. by Wen-Xue Li (189757)

Terpenoids decrease single-channel activity of L-AChRs elicited by ACh. by Guillermina Hernando (553795)

Simulated effects of increased pCREB combined with decreased pCaMKIIα on time courses of molecular pathways and synaptic weight W after IA training. by Yili Zhang (540283)

“…(A2) 3D plot of synaptic weight W at day 7 after training with <i>k</i>_{<i>basalp_creb</i>} increasing from the standard value in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010239#pcbi.1010239.t001" target="_blank">Table 1</a> to 300% of the standard value, and <i>k</i>_{<i>basalp_CaMKII</i>} decreasing from the standard value in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010239#pcbi.1010239.t001" target="_blank">Table 1</a> to 50% of the standard value, with increased binding of MeCP2, Sin3a and HDAC2 (A2). …”

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Conditioning with glucose and sodium ions decreases chemotaxis to sodium ions and glucose, respectively. by Masahiro Tomioka (430683)

Gefitinib and erlotinib decreased cyclin-D1 without activation of caspase-3. by Satoshi Koyama (784927)

ERG amplitude and peak latency gradually decreased after the continuous dark exposure. by Dake Li (2940168)

Decreased primary seed dormancy and vivipary phenotype of <i>abi4</i>. by Kai Shu (424728)

iC3b level decreases in HCV infected patient sera. by Hangeun Kim (591159)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Decreased retrograde flow via lowered blood viscosity affects valve morphogenesis. by Julien Vermot (257990)

“…<p>(A–D) Flow pattern at 48 hpf in (A) control and after (B) <i>gata1</i>, (C) <i>gata2</i>, and (D) <i>gata1/2</i> knock down. …”

Vinculin protein levels are severely decreased in Paxillin- and FAK-deficient zebrafish embryos. by Sofia Hirth (2556928)

Stx16-depleted MDCK monolayer show decreased transepithelial resistance (TER). by Jae-Joon Jung (139625)

Transient silencing of APIP decreases the growth of the HeLa cells in MTA medium. by Camille Mary (291547)

Akt inhibition by DEBC decreases membrane lipid rafts defined by density floatation. by Fumin Dong (664375)